Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2011, Vol. 16 ›› Issue (4): 461-467.
Previous Articles Next Articles
WANG Xiao-jin , SUN Jian-guo , PENG Ying , WANG Guang-ji
Received:
2011-03-08
Revised:
2011-03-22
Published:
2011-06-22
CLC Number:
WANG Xiao-jin , SUN Jian-guo , PENG Ying , WANG Guang-ji. Research progresses of free radical scavengers treating with ischemic stroke[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(4): 461-467.
[1] Lopez AD, Mathers CD, Ezzati M,et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data[J]. Lancet, 2006,367(9524):1747-1757. [2] Doeppner TR ,Hermann DM. Free radical scavengers and spin traps - therapeutic implications for ischemic stroke[J]. Best Practice & Research Clinical Anaesthesiology, 2010,24(2010):511-520. [3] 王志平,孙红斌. 氧自由基与缺血性卒中[J]. 西南军医, 2010,12(3):534-536. [4] Otomo E, Tohgi H, Kogure K,et al. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters[J]. Cerebrovasc Dis, 2003,15(3):222-229. [5] Abe M,Kaizu K ,Matsumoto K. A case report of acute renal failure and fulminant hepatitis associated with edaravone administration in a cerebral infarction patient[J]. Ther Apher Dial, 2007,11(3):235-240. [6] Hishida A. Clinical analysis of 207 patients who developed renal disorders during or after treatment with edaravone reported during post-marketing surveillance[J]. Clin Exp Nephrol, 2007,11(4):292-296. [7] Mitsubishi Tanabe Pharma Corporation.Safety and pharmacokinetics of MCI-186 in subjects with acute ischemic stroke[EB/OL].2010; Available from: http://www.clinicaltrials.gov/ct2/. [8] Unno Y,Katayama M ,Shimizu H. Does functional outcome in acute ischaemic stroke patients correlate with the amount of free-radical scavenger treatment? A retrospective study of edaravone therapy[J]. Clin Drug Investig, 2010,30(3):143-155. [9] Kikuchi K, Kawahara K, Miyagi N,et al. Edaravone: a new therapeutic approach for the treatment of acute stroke[J]. Med Hypotheses, 2010,75(6):583-585. [10] Watanabe T,Tahara M ,Todo S. The novel antioxidant edaravone: from bench to bedside[J]. Cardiovasc Ther, 2008,26(2):101-114. [11] Hess DC. NXY-059: a hopeful sign in the treatment of stroke[J]. Stroke, 2006,37(10):2649-2650. [12] Shuaib A, Lees KR, Lyden P,et al. NXY-059 for the treatment of acute ischemic stroke[J]. N Engl J Med, 2007,357(6):562-571. [13] Wang CX ,Shuaib A. Neuroprotective effects of free radical scavengers in stroke[J]. Drugs Aging, 2007,24(7):537-546. [14] Diener HC, Lees KR, Lyden P,et al. NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials[J]. Stroke, 2008,39(6):1751-1758. [15] Ginsberg MD, Becker DA, Busto R,et al. Stilbazulenyl nitrone, a novel antioxidant, is highly neuroprotective in focal ischemia[J]. Ann Neurol, 2003,54(3):330-342. [16] Ley JJ, Belayev L, Saul I,et al. Neuroprotective effect of STAZN, a novel azulenyl nitrone antioxidant, in focal cerebral ischemia in rats: dose-response and therapeutic window[J]. Brain Res, 2007,1180:101-110. [17] Sun Y, Jiang J, Zhang Z,et al. Antioxidative and thrombolytic TMP nitrone for treatment of ischemic stroke[J]. Bioorg Med Chem, 2008,16(19):8868-8874. [18] Schmid-Elsaesser R, Zausinger S, Hungerhuber E,et al. Monotherapy with dextromethorphan or tirilazad-but not a combination of both-improves outcome after transient focal cerebral ischemia in rats[J]. Exp Brain Res, 1998,122(1):121-127. [19] van der Worp HB, Kappelle LJ, Algra A,et al. The effect of tirilazad mesylate on infarct volume of patients with acute ischemic stroke[J]. Neurology, 2002,58(1):133-135. [20] Zhang S, Wang L, Liu M,et al. Tirilazad for aneurysmal subarachnoid haemorrhage[J]. Cochrane Database Syst Rev, 2010(2):CD006778. [21] Salom JB, Perez-Asensio FJ, Burguete MC,et al. Single-dose ebselen does not afford sustained neuroprotection to rats subjected to severe focal cerebral ischemia[J]. Eur J Pharmacol, 2004,495(1):55-62. [22] Green AR ,Shuaib A. Therapeutic strategies for the treatment of stroke[J]. Drug Discov Today, 2006,11(15/16):681-693. [23] Thiyagarajan M,Kaul CL ,Sharma SS. Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats[J]. Br J Pharmacol, 2004,142(5):899-911. [24] Sheng H, Enghild JJ, Bowler R,et al. Effects of metalloporphyrin catalytic antioxidants in experimental brain ischemia[J]. Free Radic Biol Med, 2002,33(7):947-961. [25] Tsubokawa T, Jadhav V, Solaroglu I,et al. Lecithinized superoxide dismutase improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats[J]. Stroke, 2007,38(3):1057-1062. [26] Reddy MK ,Labhasetwar V. Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury[J]. FASEB J, 2009,23(5):1384-1395. [27] Chen TY, Lee MY, Chen HY,et al. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice[J]. J Pineal Res, 2006,40(3):242-250. [28] Lin HW,Lee EJ. Effects of melatonin in experimental stroke models in acute, sub-acute, and chronic stages[J]. Neuropsychiatr Dis Treat, 2009,5:157-162. [29] Kilic E, Kilic U, Reiter RJ,et al. Prophylactic use of melatonin protects against focal cerebral ischemia in mice: role of endothelin converting enzyme-1[J]. J Pineal Res, 2004,37(4):247-251. [30] Tai SH, Hung YC, Lee EJ,et al. Melatonin protects against transient focal cerebral ischemia in both reproductively active and estrogen-deficient female rats: the impact of circulating estrogen on its hormetic dose-response[J]. J Pineal Res, 2011,50(3):292-303. [31] Prokai L,Prokai-Tatrai K, Perjesi P,et al. Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection[J]. Proc Natl Acad Sci U S A, 2003,100(20):11741-11746. [32] Wang MG, Li CS, Gao CJ,et al. [The therapeutic effect of small dose of estrogen on cerebral infarction] [J]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 2008,20(11):671-673. [33] Raval AP, Hirsch N, Dave KR,et al. Nicotine and estrogen synergistically exacerbate cerebral ischemic injury[J]. Neuroscience, 2011 Feb 18. [Epub ahead of print] [34] Jamieson DG ,Skliut M. Gender considerations in stroke management[J]. Neurologist, 2009,15(3):132-141. [35] Taipei Medical University WanFang Hospital.Polymorphism of Estrogen Genes in Stroke[EB/OL].2010; Available from: http://www.clinicaltrials.gov/ct2/. [36] Chamorro A, Planas AM, Muner DS,et al. Uric acid administration for neuroprotection in patients with acute brain ischemia[J]. Med Hypotheses, 2004,62(2):173-176. [37] Romanos E, Planas AM, Amaro S,et al. Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke[J]. J Cereb Blood Flow Metab, 2007,27(1):14-20. [38] Amaro S, Soy D, Obach V,et al. A pilot study of dual treatment with recombinant tissue plasminogen activator and uric acid in acute ischemic stroke[J]. Stroke, 2007,38(7):2173-2175. [39] Fundacion Clinic per a la Recerca Biomédica .Efficacy Study of Combined Treatment With Uric Acid and rtPA in Acute Ischemic Stroke (Urico-Ictus) [EB/OL].2009; Available from: http://www.clinicaltrials.gov/ct2/. [40] Harrison FE ,May JM. Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2[J]. Free Radic Biol Med, 2009,46(6):719-730. [41] Ersahin M, Toklu HZ, Cetinel S,et al. Alpha lipoic acid alleviates oxidative stress and preserves blood brain permeability in rats with subarachnoid hemorrhage[J]. Neurochem Res, 2009,35(3):418-428. [42] Packer L,Tritschler HJ ,Wessel K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid[J]. Free Radic Biol Med, 1997,22(1/2):359-378. [43] Zhang S, Liu Y, Zhao Z,et al. Effects of green tea polyphenols on caveolin-1 of microvessel fragments in rats with cerebral ischemia[J]. Neurol Res, 2010,32(9):963-970. [44] 高平章,吴洪,黄俊来. 黄芩中黄酮类成分在组织损伤中抗氧化作用的研究进展[J]. 海峡药学, 2009,21(6):1-4. [45] 刘畅,闽连秋,季占胜. 丹参对局灶性脑缺血大鼠氧化应激反应的保护效应[J]. 中国临床康复, 2006,10(3):37-39. [46] Kuang P,Tao Y,Tian Y. Effect of radix Salviae miltiorrhizae on nitric oxide in cerebral ischemic-reperfusion injury[J]. J Tradit Chin Med, 1996,16(3):224-227. [47] Rong ZT, Gong XJ, Sun HB,et al. Protective effects of oleanolic acid on cerebral ischemic damage in vivo and H(2)O(2)-induced injury in vitro[J]. Pharm Biol, 2010 Aug 5. [Epub ahead of print] [48] Shin JA, Lee H, Lim YK,et al. Therapeutic effects of resveratrol during acute periods following experimental ischemic stroke[J]. J Neuroimmunol, 2011,227(1/2):93-100. [49] 马宏跃, 李伟霞, 尚尔鑫,等. 基于抗氧化活性的不同制法当归-川芎药对配伍比例研究[J]. 中国临床药理学与治疗学, 2010,15(6): 631-635. [50] 顾兵, 程翔, 金建波,等. 脑缺血动物模型及其实验治疗学应用[J]. 中国临床药理学与治疗学, 2010, 15(9) : 1074-1080. [51] Evenson KR, Foraker RE, Morris DL,et al. A comprehensive review of prehospital and in-hospital delay times in acute stroke care[J]. Int J Stroke, 2009,4(3):187-199. |
[1] | WANG Kun, XU Peipei, ZHOU Lanlan, LU Sheng. Mechanism of neuroprotective effect of ginsenoside Rg1 regulating Epac1/Rap1 signaling pathway in rats with ischemic stroke [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 721-727. |
[2] | LI Qinghua, ZHAO Yan, ZHAO Haigang, GAO Pengfei, XU Bingxin. Value of ABCB1 G2677T gene polymorphism detection in lipid-lowering therapy with atorvastatin in patients suffered from ischemic stroke [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 633-640. |
[3] | QIN Wenxiu, XU Junfeng, YANG Ting, WANG Pingfei. Research progress on signaling pathway of tanshinoneIIA in treatment of nerve injury after ischemic stroke [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 705-713. |
[4] | FU Hong, TIAN Lei. Individualized precision therapy for patients with ischemic stroke and hypertension [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 870-876. |
[5] | LIANG Meifang, CHEN Qingzhuang, YANG Peiqun, WANG Yong. Efficacy and safety of generic and branded atorvastatin in patients with ischemic stroke/transient ischemic attack: A real-world study [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 785-792. |
[6] | XIA Chunyong, ZHANG Zuowen, HE Xiaoyan, LIU Jie, LI Xiaoya, CHANG Qiuhong, QIN Lijuan, CAO Zhenming, DING Ling. Correlation between CYP2C19 gene polymorphism and individualized medication in patients with ischemic stroke [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(3): 318-323. |
[7] | ZHAO Hailing, ZHANG Haojun, ZHAO Tingting, YAN Meihua, DONG Xi, MA Liang, LI Ping. Association between the polymorphism of PNPLA2 gene and the risk of ischemic stroke in type 2 diabetic patients in Chinese Han Population [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 664-669. |
[8] | CHEN Yanbin, DENG Shanshan. Effect of Xingnaojing injection on the expression of hypoxia-inducible factor-1α in patients with acute cerebral infarction [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(7): 821-824. |
[9] | LIU Zhengdong, ZHENG Ning. Correlation of TMAO and Lp-PLA2 levels in patients with atherosclerotic ischemic stroke [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(6): 684-688. |
[10] | MA Honggang,PAN Qinmei,ZHU Feifei,WANG Yaxian,WANG Zhuang. Relationship between leukotriene B4,carotid plaque and progressive ischemic stroke [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(6): 689-693. |
[11] | CHEN Tao, YAN Yongxing, SHEN Yonghui. Application of serum B type natriuretic peptide precursor and blood pressure variability in patients with non-cardiogenic ischemic stroke [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(5): 570-573. |
[12] | YE Zhuang , LI Zhi-qi. Progress in umbilical cord blood transplantation for hypoxic-ischemic brain injury and ischemic stroke [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(4): 450-454. |
[13] | WAN Mei, ZHOU Zhi-ming. Research progress in effects of VEGF and MMP-9 on ischemic stroke [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(3): 344-348. |
[14] | CHEN Chuang. Protection and mechanism of extract of Phyllanthus emblica L. on focal cerebral ischemia-reperfusion injury in rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(9): 991-994. |
[15] | LIU Bei, LIANG Sheng-wang. Progress of metabonomic study on cerebral ischemic stroke [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(7): 828-834. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||